Sign in
4

Changes in Ownership

Spero Therapeutics, Inc. Filed Acc 0000899243-23-003942

Chief Medical Officer acquired 265,957 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
HAMED KAMAL Chief Medical Officer 2023-02-01 Grant or award +265,957 475,957 D
Loading xslF345X03/doc4.xml…